LGALS8 and glioblastoma: This approach identified LGALS8 (Galectin-8), a glycan-binding protein involved in ECM–integrin interactions, which is frequently upregulated in GBM and associated with poor prognosis by promoting adhesion, migration, proliferation, and apoptosis resistance (Suppl Fig. 9B).